SCHEMBL7589923

SCHEMBL7589923

Nc1nc2c(ncn2CCC(=O)NCC(O)CO)c(=O)[nH]1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TK1 P04183 2/20 0.57
HPRT1 P00492 10/20 0.55
BLM P54132 2/20 0.54
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
CYP3A4 P08684 1/20 0.54
NFKB1 P19838 1/20 0.54
VCP P55072 1/20 0.54
KMT2A Q03164 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HIF1A Q16665 1/20 0.54
PNP P00491 4/20 0.51
USP2 O75604 1/20 0.51
TSHR P16473 1/20 0.51
EDNRA P25101 1/20 0.51
HTR2A P28223 1/20 0.51
RECQL P46063 1/20 0.51
HBB P68871 1/20 0.51
HSD17B10 Q99714 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570457 0.88 TK1 (0.56) TK1HPRT1BLMMEN1ALDH1A1
SCHEMBL7570078 0.85 TK1 (0.65) TK1HPRT1BLMMEN1ALDH1A1
SCHEMBL7396686 0.84 HPRT1 (0.54) HPRT1PNP
SCHEMBL7567095 0.84 TK1 (0.60) TK1HPRT1BLMPNPUSP2
SCHEMBL7575116 0.83 TK1 (0.59) TK1HPRT1BLMPNPUSP2
Buciclovir SCHEMBL571079 0.82 TK1 (0.67) TK1HPRT1BLMMEN1ALDH1A1
Buciclovir SCHEMBL349779 0.82 TK1 (0.67) TK1HPRT1BLMMEN1ALDH1A1
Buciclovir SCHEMBL10918840 0.82 TK1 (0.67) TK1HPRT1BLMMEN1ALDH1A1
SCHEMBL7572289 0.81 TK1 (0.60) TK1HPRT1BLMMEN1ALDH1A1
SCHEMBL5253451 0.81 TK1 (0.48) TK1HPRT1BLMMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1237890-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES Neotherapeutics, Inc. (US) 2002-09-11 EP claimed
US-6297226-B1 TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE NEOTHERAPEUTICS, INC. 2001-10-02 US claimed
WO-2001029039-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES NEOTHERAPEUTICS, INC. (US) 2001-04-26 WO claimed
EP-1237890-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES Neotherapeutics, Inc. (US) 2002-09-11 EP disclosed
US-6297226-B1 TREATING A DISEASE OR A CONDITION IN A MAMMAL TREATABLE BY INHIBITING THE ACTIVITY OF A MONOAMINE OXIDASE NEOTHERAPEUTICS, INC. 2001-10-02 US disclosed
WO-2001029039-A1 SYNTHESIS AND METHODS OF USE OF 9-SUBSTITUTED GUANINE DERIVATIVES NEOTHERAPEUTICS, INC. (US) 2001-04-26 WO disclosed